UR Medicine Obstetrics and Gynecology
Rochester, New York, 14620, United States
NCT Number: NCT03504592
This project will utilize MHealth technology to address the barriers providers and obstetric patients experience when reporting blood glucose results. Half of the participants will record their blood glucose values with the assistance of a smartphone device, the other half will continue in the traditional care method of the clinic.
Looking for future studies?
Notify Me18 year–60 year
Female
Interventional
Not applicable
Rochester, New York, 14620, United States
This will be a prospective single center randomized trial piloting the use of mHealth applications in an obstetric population with diabetes. Participants will be enrolled in the study after the diagnosis of diabetes is made in pregnancy for those with gestational diabetes, or for patients with preexisting diabetes they will be enrolled upon initiation of prenatal care. Participants will be randomized to traditional care or mHealth intervention. Outcomes will include completeness and accuracy of the participant glucose log, unscheduled health care access episodes in the pregnancy, patient satisfaction, percentage of glucose values at goal and percent change in Hemoglobin A1C.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Glucose logs will be assessed by provider for completeness and accuracy
Time frame: Every 2 weeks through study completion, up to 42 weeks
The number of values reported to the provider out of the number that should have been collected during the time period, expressed as a percent, as well as the number of values reported that were verified accurate by the meter out of the total number of values reported in the time frame expressed as a percent.
Time frame: Once prior to exiting the study, an average of 42 weeks
Responses to patient satisfaction survey
Time frame: Every 2 weeks through study completion, up to 42 weeks
% of glucose values at goal during the study period
Time frame: Once prior to exiting the study, up to 42 weeks
% of change in values of HbA1C during the study period
Time frame: through study completion, up to 42 weeks
Number of clinic visits during the study period
Time frame: through study completion, up to 42 weeks
Number of unanticipated or unscheduled health care visits during the study period
University of Rochester
Other
Utilizing mHealth to Improve Diabetes in an Obstetric Population
Acronym: SUGAR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05553275
Diabetes Mellitus, Diabetes, Gestational
Houston, Texas, United States
View Trial DetailsNCT07336914
Diabetes Mellitus, Diabetes, Gestational
Peshawar, Khyber Pakhtunkhwa, Pakistan
View Trial DetailsNCT06127823
Diabetes Mellitus, Diabetes, Gestational
Herlev, Denmark
View Trial DetailsNCT04724330
Body Weight, Body Weight Changes
Baltimore, Maryland, United States
View Trial Details